Adipo Therapeutics, LLC, a late pre-clinical biopharmaceutical company developing treatments for obesity and related metabolic disorders, announced the positive results for a key study demonstrating promising results using human tissue samples.
Read MoreThe U.S. Food and Drug Administration has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease.
Read MoreCatamaran, a leading provider of technology and pharmacy benefit management services, today announced it has been awarded HCIT contracts to provide implementation, adjudication, and certain PBM services to the State of Indiana’s Medicaid program. The contracts are for a total of six years, not including two one-year options, … Read More
